Publications by authors named "Michael Cerra"

Claim this Profile
F
First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor.
Vidya Perera, Zhaoqing Wang, Joseph Luettgen, Danshi Li, Mary DeSouza, Michael Cerra

Clin Transl Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.
Simon J Wilson, Fraz A Ismat, Zhaoqing Wang, Michael Cerra, Hafid Narayan

Arterioscler Thromb Vasc Biol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-to-plasma vaniprevir (MK-7009) concentration ratios in HCV-infected patients.
D Hamish Wright, Luzelena Caro, Michael Cerra, Paul Panorchan, Lihong Du

Antivir Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of simvastatin on the pharmacokinectics of sitagliptin.
Michael Cerra, Wen-Lin Luo, Susie Xiujiang Li, Catherine Matthews, Edward A O'Neill

J Popul Ther Clin Pharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.
Hideaki Dote, David Cerna, William E Burgan, Donna J Carter, Michael A Cerra

Clin Cancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
Kevin Camphausen, David Cerna, Tamalee Scott, Mary Sproull, William E Burgan, Michael A Cerra

Int J Cancer· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.
Elizabeth E A Bull, Hideaki Dote, Kristin J Brady, William E Burgan, Donna J Carter, Michael A Cerra

Clin Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional signature of flavopiridol-induced tumor cell death.
Xing Lü, William E Burgan, Michael A Cerra, Eric Y Chuang, Mong-Hsun Tsai

Mol Cancer Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci.
Kevin Camphausen, Kristin J Brady, William E Burgan, Michael A Cerra, Jeffery S Russell

Mol Cancer Ther· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.
Kevin Camphausen, William Burgan, Michael Cerra, Kelli A Oswald, Jane B Trepel

Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.
Jeffery S Russell, Kristin Brady, William E Burgan, Michael A Cerra, Kelli A Oswald

Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis